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Nifurtimox and eight structurally related 5-nitrofuran
compounds active against Trypanosoma cruzi were tested for
genotoxicity in the wing somatic mutation and recombination
test in Drosophila melanogaster. Nifurtimox, compound ada
and compound IB were clearly mutagenic and recombino-
genic whereas the remaining six compounds were negative.
In contrast to the situation in bacterial mutagenicity tests,
nitroreductase activity is probably not decisive for the
genotoxicity of these compounds in Drosophila. The three
non-genotoxic nitrofurans with high antiparasitic activity are
promising candidates for the replacement of nifurtimox.
However, these compounds require further genotoxicity
testing in eukaryotic assay systems for a final evaluation.
Introduction
5-Nitrofurans are a large group of synthetic nitro compounds used
worldwide for various purposes, as human and veterinary drugs,
food additives or preservatives. For this reason, many possible
routes of human exposure to these chemicals exist (for a review,
see Bryan, 1978). Nifurtimox [l-((5-nitrofurfurylidene)amino)-
3-methylthiomorpholine-1,1 -dioxide] is the most effective
5-nitrofuran for the treatment of Chagas' disease which affects
107 people in Central and South America and whose aetiological
agent is Trypanosoma cruzi. The trypanocidal effect of nifurtimox
(nfx) may implicate several mechanisms such as direct inhibition
of biosynthetic reactions (DNA, RNA and protein synthesis), as
well as breakage and degradation of macromolecules by oxygen
radicals generated in the parasite. Nevertheless, the knowledge
of the mode of action of this drug on T. cruzi is still incomplete
(Goijman and Stoppani, 1985; Goijman et ai, 1985). In addition,
nfx possesses some side effects in humans. A variety of
genotoxic effects in numerous organisms from prokaryotes to
mammals are known (see Table I for a summary). On account
of poor data, carcinogenicity (in rats) is doubtful (Bryan, 1978).
For all these reasons, a safer and also cheaper substitute for nfx
is needed, because Chagas' disease has enormous social and
economical implications in America.
Ten new derivatives structurally related to nfx have been
synthesized from 5-nitrofurfural and the corresponding N-amino
heterocyclic compounds and have been tested for trypanocidal
activity against T. cruzi as potential alternative antichagasic drugs
(Mester etal., 1987). Compounds in which the heterocyclic
moieties are of the l,2,4-triazol-4-yl and pyridin-1-yl group
clearly show higher activity against T. cruzi than those of the
4-thiazine-1,1-dioxide (nfx) and adamantane group. The purpose
of the present work is to assess the possible genotoxicity of eight
of the new derivatives and nfx as a reference in an eukaryotic
test system.
The mutagenicity and possible carcinogenicity of nitrofurans
may be due to the presence of two potentially reactive functional
groups: the 5-nitro group and the heterocyclic substituent at the
2-position of the furan ring. The basic requirement for
mutagenicity of nfx in bacterial systems is the reduction of the
5-nitro compound by at least three nitrofuran reductases
(McCalla, 1983) followed by cleavage to the open chain nitrile.
This is supported by the fact that nitroreductase-deficient bacteria
are resistant to the lethal and mutagenic action of nfx (Nagel,
Table I. Summary of results obtained in genotoxicity tests with nifurtimox
Test system Results References
S. typhimurium
His"1" reversion (TA100) +
His+ reversion (TA100) +
His"1" reversion (TA100) +
His+ reversion (UTK8414) ±
Ara test (BA13) +
His+ reversion
(TA100, Nfz resistant)
His"1" reversion (TA98, TA1535,
TA1537, TA1538)
His+ reversion (TA1535, TA1538) -
Escherichia coli
Arg+ reversion +
Allium cepa
Chromosome breaks and
decreased mitotic index +
Drosophila melanogaster
Sex-linked recessive lethals +
Mouse
Micronuclei +
Sperm-head abnormalities +
Rat
Chromosomal aberrations +
Carcinogenesis ?
Human
Chromosomal aberrations
(lymphocytes) +
(S9=)Ferreira and Ferreira, 1986.
(S9-)Nagel and Nepomnaschy, 1983.
Ebringer and Bencova, 1980;
Nagel, 1987.
Nagel, 1987.
(S9-)Alejandre-Duran et ai, 1988.
(S9=) Nagel, 1987.
(S9=) Nagel and Nepomnaschy, 1983.
Ebringer and Bencova, 1980.
Ohnishi et ai, 1980.
Spano and Takahashi, 1981.
Spano and Takahashi, 1981.
Navarro et ai, 1984;
Gorla and Castro, 1985.
Navarro and Nagel, 1984.
Spano and Takahashi, 1981.
Bryan, 1978.
Navarro et ai, 1984.
- : negative results (non-genotoxic).
+ : positive results (genotoxic).
S 9 - : addition of S9 mixture decreased the mutagenicity.
S9 = : addition of S9 mixture did not affect the results.
?: doubtful results, not very extensively studied.
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1987). Another point to be taken into account is that excision
repair enzymes are involved in the processing of lesions induced
by nfx (Nagel, 1987). Nitroreduction and ring opening also occur
in mammalian systems involving a variety of enzyme activities
like xanthine oxidase, NADP-cytochrome C reductase and
aldehyde oxidase (McCalla, 1983). Docampo and Stoppani (1979)
have suggested that the specific activity of nfx against T. cruzi
may be mediated by active oxygen species. The formation of
nitrofuran free radicals may result in oxygen-derived metabolites
(Docampo etal., 1981; Moreno etal., 1984; Moreno and
Docampo, 1985) which have been proposed to be responsible,
in part, for the cytotoxic effects of nfx.
The variable results obtained in the different bacterial
mutagenicity test systems with 5-nitrofurans (Alejandre-Duran
etal., 1988; Ferreira and Ferreira, 1986; Nagel and
Nepomnaschy, 1983; Ohnishi etal., 1980) motivated us to
choose an in vivo eukaryotic system, taking into account that the
new drugs are intended for use in humans. Furthermore,
genotoxic activity observed in bacteria always needs confirmation
in eukaryotic cells (Ashby, 1986). Drosophila melanogaster is
a good candidate for this purpose. The standard germline assay
for sex-linked recessive lethals (SLRL) is well validated.
However, it has particular disadvantages with respect to time
requirements, high numbers of tests needed, assay sensitivity,
etc. The role of this test system in the evaluation of potential
mammalian genotoxins has been discussed recently by Vogel
(1987). We decided to use the somatic mutation and
recombination test (SMART) (Graf et al., 1984; Wiirgler and
Vogel, 1986) in wing cells because it allows to monitor different
genetic endpoints: somatic mutation and mitotic recombination.
This wing spot test is already validated with —200 chemicals
and complex mixtures so far. The possibility to detect
recombinogenic activity is important because of a possible
connection with the carcinogenicity of different compounds
(Cairns, 1981). The inexpensive and rapid performance of the
wing spot test made this somatic test system the more adequate
for our purpose.
Materials and methods
Chemical compounds
All the chemical compounds tested for mutagenicity have in common the
5-nitrofurfural ring and differ in the A'-aminoheterocyclic side chain. The
compounds named IB [l-((5-nitrofurfurylidene)amino)pyrazole], ID [l-((5-nitro-
furfurylidene)amino)-l,2,4-triazole], IE [l-((5-nitrofurfurylidene)amino)-benzimi-
dazole], 1G [l-((5-nitrofurfurylidene)amino)indazole], 1H [3,5-bis-(methylthio)-4-
((5-nitrofurfurylidene)amino)-l,2-4-triazole], II [l-methyl-3-methylthio-4-
((5-nitrofurfurylidene)amino)-l,2,4-triazole], IK [l-((5-nitrofurfurylidene)amino)
4,6-diphenylpyridine-2-one] have previously been described by Mester et al.
(1987). The compound ada [l-((5-nitrofurfurylidene)amino)adamantane] as well
as the former seven were all synthesized and made available to us by Drs D.Sanz
and R.Claramunt (Dep. Quimica Organica, Fac. Ciencias, UNED, Madrid, Spain)
and Dr. B.Mester (Univ. de la Republica, Montevideo, Uruguay). Nifurtimox
[l-((5-nitrofurfurylidene)amino)-3-methyl-thiomorpholine-l, 1-dioxide; CAS No.
23256-30-6] was also kindly provided by Dr R.Claramunt. The abbreviations,
molecular weights and structural formulae are found in Figure 1. Further analytical
data of these compounds are found in Mester et al. (1987).
All the compounds were dissolved in 5% Tween 80 (Serva, Heidelberg, FRG)
together with 5% ethanol (Merck, Darmstadt, FRG).
Larval feeding
Eggs from a cross of optimally fertile flies (see below) were collected for 8 h
in culture bottles containing standard commeal-sugar-agar medium with extra
live yeast. On day 3, the larvae were collected from the bottles using a 20%
sodium chloride solution. The 3-day-old larvae were then put into plastic vials
containing a special instant medium: the solutions of the various compounds were
used to prepare Drosophila Instant Medium (Formula 4-24, Carolina Biological
Supply Co., Burlington, NC, USA). 2 ml of solution were always added to an
equal volume of powdered Instant Medium in a vial. Negative water and solvent
Abbreviation
IB
ID
1E
1G
1H
11
IK
nfx
ada
Molecular formula
(mw)
C8H6N4O3
(206)
C7H5N5O3
(207)
C12H8N4O3
(256)
C12H8N4O3
(256)
C9H9N5°3S2
(299)
C9H9N5°3S2
(299)
C22H15N3O4
(385)
C1OH13N3O5S
(287)
C15H16N2O3
(272)
Structural
0, N'V"
n ji
0,N/XT*
0 N^ n^**^ f
0-N 0 (
formula
-H=N-N. J.
MeS
S xMe
Ph
:H=N-N^)-Ph
(f
H=N-N^0,
H,C
H = N O
Fig. 1. Abbreviations, molecular weights and structural formulae of the
compounds tested.
controls were included. The larvae were fed on this medium for the rest of their
development ( —48 h until pupation).
Somatic mutation and recombination test
The following cross of flies carrying markers on the left arm of chromosome
3 was used: mwh females mated to flPlIntfLRjTMS, Ser males. Detailed
information on the genetic markers is given by Lindsey and Grell (1968). The
mutation fir3 is described by Garcia-Bellido and Dapena (1974). The surviving
flies were collected from the treatment vials on days 10-12 after egg laying.
Flies of the trans-heterozygous (mwh + I + fir3) genotype were stored in 70%
ethanol. For the analysis, wings were mounted in Faure's solution (gum arabic
30 g, glycerol 20 ml, chloral hydrate 50 g and water 50 ml) and were scored
under a compound microscope at 400 x magnification for the occurrence of mosaic
spots. Different types of spots were recorded separately, namely single spots
showing either the multiple wing hairs (mwh) or the flare (fir) phenotype, and
twin spots showing adjacent mwh and fir areas. Single spots are produced either
by mitotic recombination between the two markers or by somatic gene mutation,
deletion or other change at one or the other marker locus; twin spots are produced
exclusively by mitotic recombination between the proximal marker fir and the
centromere. In each case, the size of a spot was determined by counting the number
of wing cells exhibiting the mutant phenotype. A detailed description of the wing
spot test is given by Graf et al. (1984).
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Table II. Summary of results obtained in the Drosophila wing spot test with nine antiparasitic drugs
Compound
Concentration
(mM)
Number
of wings
Spots
Small
spots
(1-2
[m =
per wing
single
cells)
2]
(number of spots)
Large single
spots
(>2 cells)
[m = 5]
diagnosis
Twin spots
[m = 5]
Total
[m =
spots
2]
Spots
mwh
with
clone
Mean number of
cell division cycles
Frequency
formation
Observed
of clone
X1O~5
Control
corrected
Control (5% Tween-5% ethanol)
0.0 295 0.20 (59) 0.06 (18) 0.02 (6) 0.28 (83) 82
Compound
0.5
1.0
5.0
10.0
20.0
Nifurtimox
0.5
1.0
5.0
10.0
20.0
Compound
10.0
20.0
Compound
10.0
20.0
Compound
10.0
20.0
Compound
10.0
20.0
Compound
10.0
20.0
Compound
10.0
20.0
Compound
10.0
20.0
ada
IB
ID
IE
1G
1H
11
IK
85
81
34
20
20
130
126
86
115
48
228
175
296
211
148
166
176
92
184
160
146
136
184
184
0.41
0.25
1.44
2.00
1.95
0.26
0.33
0.31
0.66
0.71
0.34
0.61
0.26
0.25
0.30
0.19
0.24
0.21
0.26
0.23
0.25
0.24
0.21
0.21
(35) +
(20)-
(49) +
(40) +
(39) +
(34)-
(41) +
(27) +
(76) +
(34) +
(77) +
(107) +
(77)-
(52)-
(44) +
(31)-
(42)-
(19)-
(48)-
(37)-
(36)-
(33)-
(38)-
(39)-
0.06
0.12
0.32
0.95
0.80
0.10
0.10
0.19
0.24
0.31
0.12
0.14
0.05
0.09
0.06
0.03
0.10
0.05
0.03
0.08
0.03
0.13
0.04
0.08
(5) -
(10)-
(11) +
(19) +
(16) +
(13)-
(12)-
(16) +
(28) +
(15) +
(27)w
(25)w
(16)-
(18)-
(9) -
(5) -
(18)-
(5 ) -
(6) -
(12)-
(4 ) -
(17)w
(7)-
(15)-
0.02
0.05
0.26
0.60
1.75
0.03
0.04
0.07
0.09
0.15
0.06
0.06
0.01
0.04
0.03
0.07
0.02
0.02
0.04
0.00
0.02
0.04
0.02
0.02
(2)i
(4)i
(9) +
(12) +
(35) +
(4)i
(5)i
(6) +
(10) +
(7) +
(14) +
(11) +
(4) -
(8)i
(4) -
(11) +
(3) -
(2) -
(7)i
(0) -
(3 ) -
(5)i
(4)-
(4) -
0.49
0.42
2.03
3.55
4.50
0.39
0.46
0.57
0.99
1.17
0.52
0.82
0.33
0.37
0.39
0.28
0.36
0.28
0.33
0.31
0.29
0.40
0.27
0.32
(42) +
(34) +
(69) +
(71) +
(90) +
(51)w
(58) +
(49) +
(114) +
(56) +
(118) +
(143) +
(97)-
(78)w
(57)w
(47)-
(63)-
(26)-
(61)-
(49)-
(43)-
(55)w
(49)-
(58)-
42
33
68
70
88
51
57
48
112
56
117
142
97
76
55
47
59
26
61
49
42
53
49
57
2.26
1.74
2.61
2.10
2.47
2.80
2.49
2.11
2.42
2.12
2.27
2.15
2.06
1.89
2.14
1.98
2.47
2.39
2.08
1.93
2.00
1.62
2.42
2.04
2.18
1.1
2.0
1.7
8.2
14.4
18.1
1.6
1.9
2.3
4.0
4.8
2.1
3.3
1.3
1.5
1.5
1.2
1.4
1.2
1.4
1.3
1.2
1.6
1.1
1.3
0.9
0.5
7.1
13.2
16.9
0.5
0.7
1.1
2.9
3.6
1.0
2.2
0.2
0.3
0.4
0.0
0.2
0.0
0.2
0.1
0.0
0.5
0.0
0.1
Statistical diagnosis according to Frei and Wurgler (1988):
m = multiplication factor; + = positive; - = negative; w = weak; i = inconclusive.
Data evaluation and statistical analysis
The evaluation of the wing spot data was performed with the computer programme
SMART (Wurgler, unpublished). For the statistical analysis, the spots as described
above were grouped into three different categories: (i) small single spots (one
or two cells in size), (ii) large single spots (three or more cells) and (iii) twin
spots. These three categories of spots were evaluated separately. More details
on the statistical analysis are given in Frei and Wurgler (1988). For the calculations,
the Kastenbaum-Bowman test was used with P = 0.05. Based on the number
of wings analysed, the number of mwh clones and the number of cells scored
in each wing (24'400), it is possible to calculate the clone formation frequency
per cell cycle and 105 cells (see also Frei and Wurgler, 1988).
Results and discussion
Each of the nine compounds tested was assayed in at least two
independent experiments using two or more different
concentrations. All compounds were tested simultaneously to
obtain quantitative data which allow for a comparative analysis.
Before evaluating the gentotoxicity of the various compounds,
it is worthwhile to consider also the toxicity of these compounds.
All the experiments were performed with concurrent water and
solvent controls. The combination of 5% Tween 80 and 5%
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ethanol in the solvent did not lead to measurable toxicity during
the 48 h chronic feeding. For solubility reasons the highest
concentration of the compounds tested was 20 mM (concentration
of the solution used to prepare the Instant Medium). Nfx and
ada were the most toxic of all compounds. With these two
compounds the 20 mM concentration corresponded to an
approximate LDgg. In addition, there were noticeable effects on
the development of the larvae and pupae, i.e. pupation of
underdeveloped larvae and late hatching of the flies. The lower
concentrations of these compounds were less toxic. The other
compounds were tested at 10 and 20 mM concentrations only.
These treatments were also toxic, but much less than with nfx
and ada, and there was no delay in development. From all these
observations, it can be concluded that the different compounds
were taken up by the larvae in a comparable and reproducible
way during the 48 h chronic feeding. Therefore, lack of muta-
genicity observed with the majority of the compounds is not due
to lack of uptake of these.
For the evaluation of the genotoxic effects, the statistical
treatment of the data as developed by Frei and Wiirgler (1988)
is used here. The pooled results and the statistical diagnoses are
shown in Table II. For the determination of the spontaneous
mutation frequency, wings of the solvent control only were
analysed for spots. Based on the frequency of total spots per wing,
the spontaneous mutation rate of 0.28 is comparable to other
control data obtained with these solvents (Wiirgler et al., 1985).
From the data given in Table II, it is evident that ada and nfx
were clearly mutagenic at concentrations between 0.5 mM and
20 mM. The corresponding dose response curves are plotted in
Figure 2. Based on the frequency of clone formation, ada was
more genotoxic than nfx by a factor of —4.5. For this reason,
more wings were analysed for nfx than for ada. Compound IB
was also clearly mutagenic, however it was much less effective
than the former two. When considering the three categories of
spots (i.e. small singles, large singles and twins) separately for
the compounds ada, nfx and IB, it is evident that all of them
gave a positive result at least at the higher two concentrations.
For the remaining six compounds the statistical evaluation leads
to the following conclusions: Compounds 1G, 1H and IK are
negative for all three categories of spots, i.e. they are
non-genotoxic. Compounds ID, IE and II gave a weak effect
at one of the two concentrations tested. This means that the
frequencies of total spots per wing were significantly increased
over the control but remained significantly below a doubling
of the spontaneous mutation rate which we require to judge
a result positive. When analysing the three categories of spots
separately in these three series, no consistent pattern of effects
is evident: In each case, only one category gave a weak or positive
result. From this, it is concluded that these outcomes were due
to chance variation. Our experience gained with this type of
statistical evaluation has shown so far that for a positive diagnosis,
the results of at least two of the three categories should be
positive. It seems likely, therefore, that the compounds ID, IE
and II are also non-genotoxic.
A more detailed analysis of the data obtained with the three
positive compounds allows to draw further conclusions.
Particularly the significant increases in twin spots demonstrate
that the three compounds are definitely recombinogenic because
this type of spot is produced by mitotic recombination exclusively.
In contrast, the large single spots are due to various initial events:
point mutation and deletion as well as mitotic recombination
between the two markers can lead to this type of spot. The ratios
of the frequencies of twins to large singles in the control and
I
I
I
2 -
COMPOUND ada
NOTJRTIMOX
Control
10 20
Fig. 2. Dose response curves obtained in the wing spot test of
D.melanogasier with nifurtimox and compound ada.
COMPOUND ada
C0NC: 20 mM TREATMENT: 48 h
UTREflTED: 20 uings • CONTROL: 295 uings
1
SINGLE SPOTS
1 2 3-4 5-8 9-16 -32 -61 -128 -256 >512
SPOT SIZE
O
•
Im
TWIN SPOTS
1 2 3-i» 5-8 9-16 -32 -64 -128 -256 >512
SPOT SIZE
Fig. 3. Spot size distributions obtained in the wing spot test of
D.melanogasier with compound ada.
the 20 mM series are as follows: control 0.33 (0.02/0.06), IB
0.42 (0.06/0.14), nfx 0.48 (0.15/0.31) and ada 2.19 (1.75/0.80).
These values indicate that the compound ada is much more
recombinogenic than the other two.
For three selected data sets the spot size distributions are plotted
in Figures 3, 4 and 5. A comparison of the two positive results
with ada (20 mM) and IB (20 mM) shows that with the former
compound a shortage of the smallest class of spots (1 cell) is
observed. The same phenomenon is also observed with nfx (data
not shown). This effect is probably due to the high toxicity of
these treatments which has an effect on the development of the
larvae. It is possible that the larvae stop feeding prematurely and
consequently the final rounds of cell division take place when
the concentration of the active mutagenic species has dropped
already. Similar effects have already been observed with other
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COMPOUND IB
CONC: 20 mM TREATMENT: 48 h
HTREATED: 175 uings D CONTROL: 295 uings
W
SINGLE SPOTS
m—11
3-4 5-8 9-16 -32 -64 -128 -256 >512
SPOT S I Z E
CD
co 2
o =>
CO
TWIN SPOTS
2 3-4 5-8 9-16 -32 -64 -128 -256 >512
SPOT S I Z E
Fig. 4. Spot size distributions obtained in the wing spot test of
D.melanogaster with compound IB.
COMPOUND IK
C O N C : 20 mM TREATMENT: 48 h
^ T R E A T E D : 184 u i n g s • CONTROL: 295 u i n g s
2 3-4 5-8 9-16 -32 -64 -128 -256 >512
SPOT SIZE
2 3-4 5-8 9-16 -32 -64 -128 -256 >S12
SPOT S IZE
Fig. 5. Spot size distributions obtained in the wing spot test of
D.melanogaster with compound IK.
mutagens (Frei and Wurgler, 1986). In contrast, the 20 mM
treatment with compound IB which is much less toxic, gives the
expected spot size distribution (Figure 4). As an example of the
negative compounds, the spot size distribution obtained with
compound IK (20 mM) shows that it is coincident with the
distribution obtained with the solvent control (Figure 5).
All three mutagenic compounds produced large single spots
of sizes up to 64 = 26 cells. Based on the fact that one round
of cell division in the wing imaginal disc lasts ~ 10—12 h, the
largest spots correspond to mutagenic events taking place at the
beginning of the third larval instar. This corresponds to the begin-
ning of the treatment. Therefore, it can be concluded that the
larvae take up these compounds and metabolize them efficiently
and quickly. The positive results obtained demonstrate that the
metabolic activity required for mutagenicity of these compounds
is present in sufficient amounts in the Drosophila larvae. It can
be assumed that the situation is similar for the compounds which
gave negative results. This means that with these compounds not
enough of possible mutagenic metabolites or none at all were
produced.
When comparing the genotoxic effects observed in our
experiments with the results obtained in other test systems, nfx
confirms previous positive results (see Table I). In particular,
the mutagenicity of nfx observed in germ cells of Drosophila (sex-
linked recessive lethals, Spano and Takahashi, 1981) is also
manifested in somatic cells. Ada and IB are newly synthesized
chemical compounds for which no mutagenicity data are available
with the exception of positive results obtained in the ara test in
Salmonella typhimurium (Alejandre-Duran etal., 1988).
However, in that test system, compound IB was more mutagenic
than ada which contrasts with the situation encountered in the
wing spot test in Drosophila. In addition, all the remaining
compounds were more or less active in the ara test, whereas they
are non-genotoxic in the somatic cells of the wing.
The mutagenicity of the nitrofurans observed in bacterial test
systems is most probably due to nitroreductase activity
(Alejandre-Duran et al., 1988; Ferreira et al., 1988; Ni et al.,
1987). These enzymes metabolize the nitrofuran moiety of the
molecule which is identical for all the compounds. The addition
of S9 mixture has no major effect on the mutagenicity. Most
probably, the situation encountered in such a procaryotic in vitro
test system does not reflect the metabolic pathways present in
an eukaryotic in vivo assay. It may be assumed that the
nitroreductase activity is of lesser importance in Drosophila. This
is suggested by the fact that six of the compounds are negative
in the Drosophila wing spot test, although they have the same
basic nitrofuran structure as the three compounds which are
positive. Therefore, other metabolic pathways could be present
which are able to metabolize the aminoheterocyclic side chain
of these compounds.
With the exception of ada, all the compounds have been tested
for antiparasitic activity in T.cruzi (Mester et al., 1987). Nfx is
among the least effective compounds, whereas compounds 1H,
II, and IK are the most effective antiparasitics. These compounds
seem to be good candidates for the substitution of nfx if we
consider that to the best of our knowledge they are non-genotoxic
in Drosophila. Although its antiparasitic activity is not yet known,
the newly synthesized compound ada is not very promising
because of its high mutagenicity and recombinogenicity herewith
documented. However, the compounds which are non-genotoxic
in Drosophila all need further testing in other eukaryotic
genotoxicity test systems for a final assessment.
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In conclusion, the screening of these nine 5-nitrofuran
compounds in the Drosophila wing spot assay has shown that
this in vivo somatic mutation and recombination test is suited for
this class of compounds and that it allows for a differentiated
evaluation of potential antiparasitic drugs with respect to
genotoxicity.
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